Anemia Clinical Trial
Official title:
A Randomized Feeding Trial of Iron-Biofortified Beans in School Children in Mexico
The objective of this cluster-randomized efficacy feeding trial was to determine the effects of consuming iron-biofortified beans (Fe-Beans) on iron status in children, compared to control beans (Control-Beans). A cluster-randomized trial of biofortified beans (Phaseolus vulgaris L), bred to enhance iron content, was conducted for 6 months.
Iron deficiency is the most common single nutrient deficiency worldwide, with the highest
burden in children and women of reproductive age. Global estimates of anemia prevalence in
school-aged children range between 25% and 46%, and iron deficiency accounts for a majority
of anemia cases. In Mexico, the national nutrition and health survey (2006) reported a
prevalence of anemia of 16.6% and iron deficiency of 17.6% (serum ferritin <12.0 µg/L),
posing a considerable health risk for children.
Interventions, including micronutrient supplementation and food fortification, have improved
iron status and reduced the prevalence of anemia in some settings. However, iron deficiency
remains an urgent public health problem and threat to child health and development. Young
children are particularly at high risk due to rapid growth, inadequate dietary intake, and
high risk of infection in resource-limited settings. Iron deficiency has been associated with
impaired cognitive function in children, and long-term impairments in physical work capacity
into adulthood.
One novel approach to reducing micronutrient malnutrition is to enhance the nutrient quality
of the diet through biofortification of staple crops that are already locally accepted and
consumed. Biofortification has consequently been recognized by the Copenhagen Consensus of
2008 as one of the top five solutions to current global health and nutrition challenges. The
success and challenges of biofortification have been documented previously. We recently
reviewed the published evidence from the three randomized efficacy trials of different
iron-biofortified crops that demonstrated varied benefits in populations, including rice in
adult Filipino women, pearl millet in school-aged children in India, and beans in women of
reproductive age in Rwanda. Findings demonstrated improvements in serum ferritin
concentrations and total body iron concentrations, with additional potential to benefit in
individuals who were iron deficient at baseline. Given this limited evidence and with no
studies from Latin America, more studies with diverse populations and locally relevant crops
are warranted before implementation of a potentially important public health intervention.
In order to target at-risk populations in Latin America, the Centro Internacional de
Agricultura Tropical (CIAT) in Colombia bred and biofortified a common black bean variety
(Phaseolus vulgaris L), the standard black bean currently consumed widely in Central America
and Mexico. In Mexico, beans have been ranked highly among the most consumed foods by
school-aged children nationwide, according to Encuesta Nacional de Salud y Nutrición, a
nationally representative nutrition survey in 2006. Biofortification has nearly doubled the
iron concentration (~100 versus ~50 mg/kg) of the standard bean variety. We hypothesized that
daily consumption of iron-biofortified beans (Fe-Beans) would improve hemoglobin, serum
ferritin, and total body iron in 6 months, compared to control beans (Control-Beans). In
order to examine this hypothesis, we conducted the first randomized efficacy trial of
iron-biofortified beans and iron status in primary school-aged children in a low-income
setting in Mexico. Special consideration was applied to assess indicators of iron status with
and without anemia and measured inflammatory markers, which can mask iron deficiency,
particularly in similar settings where the prevalence of infection is high.
The objective of this cluster-randomized efficacy feeding trial was to determine the effects
of consuming iron-biofortified beans (Fe-Beans) on iron status in children, compared to
control beans (Control-Beans).
The long-term goal of this study is to determine if iron bio-fortification of beans is an
efficacious and potentially effective strategy to improve iron status of at-risk populations
in resource-limited settings.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT00801931 -
Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders
|
Phase 1/Phase 2 | |
Completed |
NCT02948283 -
Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia
|
Phase 1 | |
Completed |
NCT03341338 -
Genes-in-Action - Hepcidin Regulation of Iron Supplementation
|
||
Completed |
NCT00060398 -
Epoetin Alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer
|
Phase 3 | |
Recruiting |
NCT05384691 -
Efficacy of Luspatercept in ESA-naive LR-MDS Patients With or Without Ring Sideroblasts Who do Not Require Transfusions
|
Phase 2 | |
Not yet recruiting |
NCT06309641 -
Methemoglobinemia Following Intravenous Iron Treatment
|
||
Completed |
NCT02930850 -
Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation
|
N/A | |
Completed |
NCT03822884 -
Pharmacokinetic/Pharmacodynamic Study of 3 Subcutaneous Single Dose Epoetin Alfa Formulations in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT02888171 -
Impact of Ferric Citrate vs Ferrous Sulfate on Iron Parameters and Hemoglobin in Individuals With CKD and Iron Deficiency
|
N/A | |
Completed |
NCT02912494 -
A Phase III Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD)
|
Phase 3 | |
Completed |
NCT02912533 -
A Long-term Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD)
|
Phase 3 | |
Completed |
NCT02384122 -
Efficacy of Octreotide on Blood and Iron Requirements in Patients With Anemia Due to Angiodysplasias
|
Phase 3 | |
Completed |
NCT02603250 -
Evaluation of Hemoglobin Measurement Tools for Child Anemia Screening in Rwanda
|
N/A | |
Completed |
NCT02176759 -
Iron Absorption From Rice Fortified With Ferric Pyrophosphate
|
N/A | |
Completed |
NCT02310113 -
Transfusion and Skeletal Muscle Tissue Oxygenation
|
N/A | |
Completed |
NCT01922479 -
Pilot Study of Ferric Carboxymaltose to Treat Iron Deficiency in Asians With Heart Failure
|
Phase 4 | |
Withdrawn |
NCT01934842 -
A Study to Compare Analyte Levels in Blood Collected Using an Investigational Collection Device With a Commercial Predicate
|
N/A | |
Completed |
NCT01693029 -
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
|
Phase 3 | |
Terminated |
NCT01535781 -
Study of the Effect of Tranexamic Acid Administered to Patients With Hip Fractures. Can Blood Loss be Reduced?
|
N/A | |
Completed |
NCT01432717 -
Study of ACE-536 in Healthy Postmenopausal Women
|
Phase 1 |